OKYO - OKYO Pharma gains after positive results from Phase 2 dry eye disease trial March, 22 2024 08:32 AM OKYO Pharma Limited 2024-03-22 08:32:58 ET More on OKYO Pharma OKYO Pharma gains on receiving FDA nod of IND for OK-101 in neuropathic corneal pain Seeking Alpha’s Quant Rating on OKYO Pharma Historical earnings data for OKYO Pharma Financial information for OKYO Pharma For further details see: OKYO Pharma gains after positive results from Phase 2 dry eye disease trial